LabSolutions CEO Guilty In $187M Telemed Billing Scheme
By Carolina Bolado · December 14, 2022, 4:40 PM EST
Jurors returned a guilty verdict Wednesday against the CEO of genetic testing company LabSolutions on accusations of orchestrating a scheme to bill $187 million to Medicare for medically unnecessary genetic testing....
To view the full article, register now.